Investing in Cannabis: David Goldstein - Founder/CEO of Potbotics
In this episode, we welcome David Goldstein, founder and CEO of Potbotics. David and his company are pushing the boundaries of medical cannabis research and product development. With products like the Potbot and Brainbot, you can get an EEG to help analyze which cannabis works best with your brain. In this fascinating discussion, Brandon and David dive into the medical side of cannabis, Israel's influence in the medical community, and the future of medical cannabis in the US.
Entrepreneur | Thursday, October 06 2016
10 Cannabis Startups You Need to Watch
New technologies like 3-D printing are being introduced. Specialized child-resistant, odorless packaging has been developed. Cannabis seed-to-sale cycles are now run with sophisticated inventory systems, business decisions are data-driven, and the industry has the same types of specialized professional services commonplace in traditional business.
This collection of notable cannabis startups spans manufacturing, distribution, retail and a few things in between. They\'re a representation of the industry developments that exist and a mere glimpse of those to come.
Vice Motherboard | Thursday, August 11 2016
This App Helps You Pick Out the Right Strain of Medical Weed
The future of medical marijuana might be at your fingertips. PotBot, a mobile app developed by the company Potbotics, helps users find out the best weed for their body, and recommend the right strain of marijuana for your particular medical condition
Forbes | Tuesday, August 16 2016
Tuesday App Roundup: Find Your Strain With PotBot, Stay Anonymous With Candid, Dubdub Your Video
New York City based PotBotics has released its PotBot app, which will help take some of the guesswork out of choosing the right strain of marijuana for what ails ya.
Medical Marijuana Innovation Through Biotechnology
Our mission is to elevate the cannabis industry to higher medical standards by streamlining the recommendation, cultivation and consumer cannabis selection process.
While others are looking to make marijuana stronger, PotBotics is looking to make it smarter. Our diverse technology offering blends robotics, artificial intelligence, DNA analysis and cannabis research to address the major pain points in the medical marijuana industry, benefiting patients, physicians, cultivators and dispensary owners. Together our three products create an enterprise technology platform for medical marijuana. Our “cannabinoid matrixes,” or specific ratios of the various chemicals in marijuana, form the underlying basis of our three main products – PotBot, BrainBot and NanoPot.
Educating Patients Through Our Virtual Budtender
PotBot is a unique medical marijuana recommendation engine that uses cutting edge neural-net algorithms to recommend cannabinoid levels and custom strains to medical marijuana patients. By combining scientific data and crowdsourced reviews, PotBot’s desktop and mobile app will guide patients toward the appropriate strain and consumption method for their specific ailments, eliminating the need for patients to experiment with different strains themselves. With PotBot’s interactive in-store kiosks, dispensaries benefit from an encrypted cloud infrastructure that helps elevate security, meet state regulations, and expedite orders.
Personalizing Medical Marijuana Recommendation
Doctors who understand the medicinal value of cannabis are frustrated by the lack of research and scientific data on medical marijuana and its use cases for treating specific symptoms and conditions. With BrainBot, PotBotics has developed a wireless EEG (electroencephalography) helmet that allows general practitioners to capture brain waves and analyze a patient’s neural response to cannabinoid stimulants so that the right strain and cannabinoid level can be recommended. By identifying and quantifying the effects different cannabinoids have on a patient, BrainBot reduces patients’ reliance on a “roll of the dice” medical marijuana recommendation.
Driving Seed Analytics To Optimize Growth
NanoPot is an advanced DNA reader that scans cannabis seeds to optimize growers’ yields. By using gene-radar technology to rapidly and accurately detect genetic fingerprints from cannabis seeds, cannabis cultivators can both understand the seed’s molecular biology and more effectively breed plants that benefit specific ailments. With NanoPot, cultivators get a fully customized growth plan with optimal amounts of irrigation, sunlight, UV films and nano fertilizers to use when growing specific strains and hybrids, reducing their reliance on outdated techniques for maximizing cannabis growth yields.
If you are interested in learning more about investment opportunities with PotBotics, please complete the inquiry form below and a member of our Investor Relations team will follow up with you shortly
Cannibinoid Whitepaper ———————————————————————
The Application of Cannabinoids and Cannabinoid Ratios for Specific Medical Treatments
The use of phytocannabinoids and synthetic cannabinoid compounds is gaining momentum for various medical applications. Research aimed at elucidating the efficacy and mechanisms of action for various cannabinoids is increasingly demonstrating their potential as therapeutics for other difficult to treat diseases such as multiple sclerosis, cancer, and epilepsy. In this whitepaper, we address the most promising cannabinoid compounds as well as their proven efficacy for medical conditions and symptom relief.
2225 E. Bayshore Road, Suite 200
Palo Alto, CA 94303
205 East 42 Street, 14th Floor New York, NY 10017 917.525.2697
Press Inquiries: Evan Nison
Partnership Opportunities: David Goldstein
@2015 PotBotics, Inc. All rights reserved. Potbotics, Potbot, Potbotics Cloud, PotBotics.com, Nanopot, Brainbot are registered trademarks of PotBotics Inc. Terms and conditions, features, support and services subject to change without notice.